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ABSTRACT
Originally considered futile degradation products, tRNA-derived RNA fragments (tdRs) have been shown
over the recent past to be crucial players in orchestrating various cellular functions. Unlike other small
non-coding RNA (ncRNA) classes, tdRs possess a multifaceted functional repertoire ranging from
regulating transcription, apoptosis, RNA interference, ribosome biogenesis to controlling translation
efficiency. A subset of the latter tdRs has been shown to directly target the ribosome, the central
molecular machine of protein biosynthesis. Here we describe the function of the mammalian tRNAPro 5ʹ
half, a 35 residue long ncRNA associated with ribosomes and polysomes in several mammalian cell lines.
Addition of tRNAPro halves to mammalian in vitro translation systems results in global translation
inhibition and concomitantly causes the upregulation of a specific low molecular weight translational
product. This tRNAPro 5ʹ half-dependent translation product consists of both RNA and amino acids.
Transfection of the tRNAPro half into HeLa cells leads to the formation of the same product in vivo. The
migration of this product in acidic gels, the insensitivity to copper sulphate treatment, the resistance to
3ʹ polyadenylation, and the association with 80S monosomes indicate that the accumulated product is
peptidyl-tRNA. Our data thus suggest that binding of the tRNAPro 5ʹ half to the ribosome leads to
ribosome stalling and to the formation of peptidyl-tRNA. Our findings revealed a so far unknown
functional role of a tdR thus further enlarging the functional heterogeneity of this emerging class of
ribo-regulators.
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Introduction
In early high-throughput studies, tRNA-derived fragments
(tdRs) were identified in a wide variety of model systems yet
they were considered as degradation products devoid of phy-
siological relevance [1]. Nowadays, with the improved deep-
sequencing protocols, tailor-made bioinformatics tools, and
accumulating functional studies it became clear that tdRs
represent a so far unknown class of regulatory ncRNAs. It
could be demonstrated that many tdRs, which include tRNA
half molecules as well as even shorter tRNA fragments (tRFs),
are specifically processed by endonucleases to participate in
and regulate diverse biological process [2]. tRNA halves and
tRNA fragments are involved in controlling cell proliferation,
cellular homoeostasis, priming of viral reverse transcriptases,
regulating gene expression, trans-generational epigenetic
inheritance, RNA processing, modulation of the DNA damage
response, tumour suppression, regulation of transposition,
neurodegeneration, ribosome biogenesis, and translation reg-
ulation [2–5]. Accumulating evidence further link misregu-
lated tRF production to certain human diseases, while other
studies highlight tRFs as potential biomarkers for disease
states [6–8].
Recently, ribosome-associated non-coding RNAs
(rancRNAs) were recognized as a new class of regulatory
ncRNAs. It was shown that small rancRNAs influence protein
synthesis by directly targeting the ribosome in organisms repre-
senting all three domains of life [9]. A major fraction of these
rancRNAs is processed from longer functional precursors
including mRNAs, snoRNAs, and tRNAs [10,11]. Functional
analyses of selected ribosome-bound tRFs revealed an unex-
pected functional heterogeneity. For example, an alkaline stress-
induced archaeal tRNAVal fragment associates with the small
ribosomal subunit and globally inhibits translation initiation by
competing with mRNA binding [12,13]. Another study suggests
that yeast ribosome-bound tRFs have the potential of inhibiting
tRNA aminoacylation [14]. On the other hand, in the human
parasite T. brucei a tRNAThr 3ʹ half associates with ribosomes
under nutrient deprivation conditions and stimulates global
translation during stress recovery [15]. Ribosome-targeted tdRs
have recently also been linked to cell proliferation inmammalian
cells and might promote cancer progression in a mouse model
[16]. These findings reveal ribosome-bound tdRs as functionally
versatile regulators capable of fine-tuning protein biosynthesis in
a stress-dependent manner.
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Despite recent studies highlighting regulatory roles during
gene expression in different model organisms, rancRNA has
not yet been studied in detail in human cells or any other
mammalian species so far. In this study, we performed screen-
ing for ribosome-bound tRFs in different mammalian cell
lines and uncovered the highly conserved tRNAPro 5ʹ half.
We demonstrate that upon ribosome-binding the tRNAPro 5ʹ
half inhibits global protein biosynthesis with the concomitant
appearance of a low molecular weight translation product,
dubbed ProTiP. Cumulative experimental evidence suggests
ProTiP to be peptidyl-tRNA likely accumulating as a by-
product of tRNAPro half-mediated translation inhibition.
Results
Expression and ribosome-association of the tRNAPro half
in mammalian cell lines
Previous deep sequencing of the small RNome in CHO-K1
cells identified differentially expressed miRNAs [17,18] and
piRNAs [19]. Here we re-analysed the data for other small
ncRNAs and indeed found indications for high expression of
tRNA halves and shorter tdRs (Fig. S1). The expression and
function of tRFs and halves were shown before to be asso-
ciated with stress in several studies, therefore, CHO-K1 cells
from different stress conditions (heat shock, cold shock, sta-
tionary phase growth, oxidative stress, and oxidative stress
followed by recovery) were used for screening for tdRs via
northern blot analysis. Since there are characterized examples
of tRFs and tRNA halves directly binding to ribosomes and in
this way regulating translation [13,15], northern blot screen-
ing was performed on total RNA and on RNA isolated from
the crude ribosome pellets in parallel. As a result of this
screen, the tRNAPro 5ʹ half was detected predominately in
the ribosome-containing pellet, but under stationary growth
conditions also in the total RNA fraction (Fig. 1A). The
tRNAPro 5ʹ half was also apparent in other mammalian cell
lines such as in HeLa, HEK, BON, NCI, and Hep3B cells (Fig.
1B). As observed in CHO cells, the tRNAPro half was consti-
tutively expressed and did not show a clear change upon stress
induction neither in HeLa nor in HEK cells (Fig. S2).
Polysome profiling and consequent northern blot analysis
confirmed the ribosome association of the tRNAPro half in
CHO, HEK, and HeLa cells. In all three cell lines the tRNAPro
half is present mainly in the 80S monosome fraction (HeLa,
HEK) and in CHO and HEK cells also in the 60S subunit peak
(Fig. 1C-E). The northern blot signal obtained in the small
ribosomal subunit fractions (e.g. Fig. 1C) most certainly
results from a spill-over from the light gradient fractions.
Binding of tRNAPro 5ʹ half to ribosomes and ribosomal sub-
units was confirmed by in vitro filter binding assays. P32-labelled
tRNAPro half was shown to bind the crude ribosomal pellets
(P100) isolated from CHO or HeLa cells (Fig. 2A). Filter binding
assay using human or yeast ribosomal subunits showed binding to
both 60 S and 40 S subunits, with slightly varying binding pre-
ferences (Fig. 2A). An unrelated short archaeal ncRNA was used
as binding specificity control [20] which resulted in no or very
diminished binding to mammalian ribosomes. The obtained
binding data with the tRNAPro half are compatible with
a binding site at or near the subunit interface. To test this assump-
tion, UV crosslinking experiments employing a 5ʹ-32P labelled and
4-Thio-U-containing tRNAPro half was performed. The tRNAPro
half crosslinked exclusively to 18S rRNA of HeLa 80S ribosomes
(Fig. 2B). Using a similarly 5ʹ-32P labelled and 4-Thio-
U-containing tRNA half from T. brucei [15] did not result in
any detectable crosslink to rRNAs (Fig. S3) therefore highlighting
the specificity of the observed effects. Employing a 3ʹ-biotinylated
and 4-Thio-U-containing tRNAPro half in crosslinking and strep-
tavidin pull-down experiments did not identify any ribosomal
protein (Table S1), thus suggesting the ribosome binding site
being primarily composed of rRNA. RNaseH-mediated cleavage
guided by anti-sense DNA oligos complementary to different
parts the 18S rRNA allowed us to narrow down the cross-
linking site(s) to the last 306 nucleotides of the 3′ end of 18S
rRNA (Fig. 2C, D). Highlighting this region in the context of the
human 80S cryo-EM structure [21] showed its location at the
subunit interface (Fig. S4). These data are therefore in line with
the assumption that both subunits contribute to the binding site as
suggested by the filter binding results (Fig. 2A).
tRNAPro 5ʹ half inhibits translation and triggers a low
molecular weight product
To test if the ribosome-associated tRNAPro half can influence
protein synthesis, in vitro translation was performed based on
a CHO cell lysate in the presence of the synthetic 35 nt long
tRNAPro half. Addition of tRNAPro half reproducibly led to an
inhibition of global protein biosynthesis to a varying extent
(Figs. 3A, B). However, when using a rabbit reticulocyte-based
translation system with a single mRNA reporter, the picture
became clearer and very low levels of protein synthesis were
reproducibly observed upon addition of the tRNAPro 5ʹ half
(Fig. 3C). Addition of other tRNA 5ʹ halves had only compar-
ably mild effects on translation (Figs. 3C, D). Addition of
a DNA version of the tRNAPro half on the other hand showed
no effect on protein biosynthesis (Fig. S5). Based on these
experiments we decided to focus our subsequent research on
the tRNAPro 5ʹ half.
During these experiments, we noticed that besides inhibition
of translation, addition of the synthetic 5ʹ tRNAPro half into
in vitro translation reactions led to the formation of a specific
band that migrates like a ~ 17 kDa product on SDS-containing
polyacrylamide gels (Figs. 3A, C). This proline tRNA half-
induced product (to which we refer to as ProTiP) is specific to
the tRNAPro 5ʹ half and is not produced in the presence of any
other tested tRNA half (Fig. 3C, E). Formation of ProTiP was
found to be dose-dependent as addition of increasing amounts
of the tRNAPro 5ʹ half stimulates its production (Fig. 3F, G).
Alignment of different tRNAPro genes shows high sequence
identities in its 5ʹ region among several species (Fig. S6) suggest-
ing a possible conservation of the tRNAPro 5ʹ half function. To test
the effect of this tRNA half on translation in other biological
systems, the same tRNAPro half was added to in vitro translation
systems based on HeLa, HEK, or yeast cell extracts. Similar to the
CHO and rabbit reticulocytes systems, addition of the tRNAPro 5ʹ
half led to global translation inhibition and accumulation of
ProTiP in all tested systems (Fig. 4A-C). We noticed that the
addition of the tRNAPro half in the presence of low concentrations
2 Y. GONSKIKH ET AL.
of the translation elongation inhibitor cycloheximide did not
inhibit but even enhanced ProTiP formation. This increased
ProTiP abundance, however, does not result from a putative
stimulatory effect of low cycloheximide concentrations on
tRNAPro half ribosome binding (Fig. S7). In cycloheximide titra-
tion experiments it turned out that only under higher
concentrations of the inhibitor also ProTiP formation was
reduced (Fig. 4D). The fact that tRNAPro half-mediated transla-
tion inhibition and ProTiP formation were observed in mamma-
lian and yeast cell extracts suggests that the ribosome-binding site
and/or themode of action is conserved between different eukaryal
translation systems. To test if ProTiP formation represents
Figure 1. Expression and ribosome association of the tRNAPro half in different mammalian cell lines. (A) Northern blot analysis of the tRNAPro 5ʹ half of 20 µg of total
RNA or 20 µg of RNA isolated from the crude ribosome pellet (P100) from CHO-K1 at several stress conditions: heat shock (heat), oxidative stress (oxid), oxidative
stress with recovery, stationary (stat) growth phase and as a control exponential (exp) growth phase. Lower panel shows the same northern blot in the region of the
tRNA half with increased contrast. (B) Northern blot analysis of the tRNAPro 5ʹ half of 30 µg total RNA isolated from HeLa, HEK, BON, NCI, and Hep3B cells. Ethidium
bromide-stained 5 S rRNA serves as a loading control. (C-E) Polysome profiling of exponentially grown CHO-K1, HeLa, and HEK cells, respectively (top panels). RNA
was isolated from the indicated fractions (free RNA, 40 S, 60 S, 80 S, and polysomes), its integrity, and identity monitored by agarose gel electrophoresis (middle
panel) and used for northern blot analysis (lower panels). Full length (FL) tRNAPro and the tRNAPro 5ʹ half are indicated.
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a peculiarity of in vitro translation systems or is also produced in
living cells, the tRNAPro half was transfected into HeLa cells.
Metabolic labelling in the presence of 35S methionine after trans-
fection led to the production of ProTiP in vivo (Fig. 4E). These
data show that tRNAPro half-mediated ProTiP production is not
solely an in vitro translation phenomenon but occurs in living
mammalian cells as well.
ProTiP formation requires genuine protein biosynthesis
Several of the above-shown experiments suggest that ProTiP
formation is a translation-dependent event. To substantiate
these observations, HeLa cell extracts were divided via 100,000
xg centrifugation into the crude ribosomal pellet (P100) and
the post-ribosomal supernatant (S100). In vitro translation
activity only occurred once P100 and S100 fractions were
combined (Fig. 4F). Addition of the tRNAPro 5ʹ half to P100
or S100 separately did neither result in translation activity nor
in ProTiP formation. However, upon combination of the P100
and S100 fractions protein synthesis occurred and caused the
appearance of ProTiP in the presence of the tRNAPro half
(Fig. 4F). This experiment demonstrates that ProTiP forma-
tion indeed requires genuine translation. Support for this
conclusion came from the fact that ProTiP synthesis could
Figure 2. Binding of the tRNAPro half to ribosomes and ribosomal subunits in vitro. (A) Binding of the P32-labelled tRNAPro 5ʹ half to the crude ribosomal pellet (P100)
and gradient-purified ribosomal subunits (40 S and 60 S) isolated from CHO cells, HeLa, and yeast cells was monitored by filter binding. Negative control (-) shows
background signals in the absence of ribosomal particles. An unrelated small ncRNA (control RNA) from H. volcanii showed no (HeLa, yeast) or severely reduced (CHO)
binding to ribosomal particles and serves as a binding specificity control. (B-C) Photocrosslinking of the tRNAPro half to human ribosomes. 5ʹ P32 – labelled tRNAPro
half-carrying 4-thio-uracils was crosslinked to crude HeLa ribosomes at 366 nm followed by protease K treatment and RNA isolation. (B) After photo-crosslinking,
RNAs were resolved on a 1% agarose gel. The ethidium bromide-stained gel and the autoradiogram thereof are shown. 18S rRNA and 28 S rRNA are labelled. (C)
After photo-crosslinking, purified RNAs were subjected to RNase H treatment guided by DNA oligos complementary to different regions of 18S rRNA and the cleavage
products were separated on 4% polyacrylamide denaturing gels. Ethidium bromide staining and autoradiogram are shown. Expected sizes of the produced rRNA
fragments are indicated above each lane.
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be influenced by the translational inhibitor harringtonine,
which immobilizes eukaryotic ribosomes immediately after
the initiation of translation. Harringtonine completely abol-
ished global translation and also the production of ProTiP in
the presence of the tRNAPro half (Fig. 4G). As mentioned
above, similar effects were observed upon addition of elevated
concentration of the tRNA translocation inhibitor cyclohex-
imide (Fig. 4D).
The chemical nature of ProTiP
ProTiP requires translation and it migrates as a ~ 17 kDa band
on SDS gels thus indicating ProTiP of being a polypeptide.
Indeed, in vitro translation followed by protease K digestion
completely eliminated the ProTiP band on the gel (Fig. 5A).
These findings are compatible with the view that addition of
tRNAPro 5ʹ half into in vitro or in vivo translation reactions
stimulates the production of one or several proteins that run as
~17 kDa products on denaturing gels. Ethidium bromide stain-
ing of the SDS gel showed that small RNAs, in particular tRNAs,
also migrated in the same region of the gel as ProTiP (Fig. 5B).
To test if ProTiP also contains RNA, in vitro translation reac-
tions were subjected to an RNase I treatment. ProTiP was shown
to be RNase sensitive since the band disappeared after nuclease
digestion (Fig. 5A). The observation that ProTiP could be
extracted into the water phase during phenol/chloroform extrac-
tion further indicates that ProTiP contains not only a peptidyl or
protein part but also an RNA component (Fig. 5C).
To better reveal the chemical identity of ProTiP, we first
focused on the characterization of its RNA part. By utilizing
a 5ʹ-32P labelled (Fig. 5D) or a 3ʹ biotinylated tRNAPro half (Fig.
S8) during in vitro translation we could clearly demonstrate that
the tRNAPro 5ʹ half itself is not part of ProTiP. To better estimate
the size of ProTiP, samples extracted via phenol/chloroform
treatment after in vitro translation were loaded on an acidic
gel. On acidic gels, ProTiP migrated in the range of the tRNA
pool, slightly above methionyl-tRNAs (Fig. 6A). To characterize
the 3ʹend of ProTiP, a polyadenylation experiment was designed.
If the RNA moiety of ProTiP has a free 3ʹ end, it will be
susceptible to polyadenylation and consequently would migrate
more slowly on polyacrylamide gels. In contrast, if the RNA 3ʹ
end is protected it would be insensitive to polyadenylation and,
thus, would not change its electrophoretic mobility.
Polyadenylation performed on RNA extracted after in vitro
translation in the presence of tRNAPro half lead to an upshift
of the majority of RNA on ethidium bromide-stained gels, while
the autoradiogram of the same gel showed that ProTiP migra-
tion remained unchanged upon polyadenylation (Fig. 6B). As
Figure 3. Effect of tRNAPro 5ʹ half on translation. (A) Autoradiogram of an SDS polyacrylamide gel after in vitro translation in the presence of the synthetic tRNAPro
half using a CHO cell lysate. (B) Quantification of six in vitro translation experiments performed with CHO cell lysates in the absence (-) or presence (+) of the tRNAPro
half. Values were normalized to the in vitro translation reaction with no tRNAPro half added. Box shows ± 25% of the mean, error bars show standard deviation. (C)
Autoradiogram of an SDS polyacrylamide gel after in vitro translation of one reporter in the absence (-) presence of various synthetic tRNA 5ʹ halves (5 or 8 µM) using
a rabbit reticulocyte cell lysate. In all cases, the tRNA 5ʹ halves are abbreviated by their respective amino acid three letter code. The asterisk marks the position of the
full-length reporter protein. (D) Quantification of three in vitro translation experiments performed with rabbit reticulocyte cell lysate and one mRNA reporter in the
presence of different tRNA 5ʹ halves (5 or 8 µM). Values were normalized to the in vitro translation reaction in the absence of the tRNAPro half. The horizontal lines
indicate the mean and the error bars show standard deviations. (E) CHO in vitro translation in the presence of 8 µM synthetic tRNA halves. The apparent tRNAPro half-
induced product (ProTiP) is indicated with a black arrowhead (here and in all panels). (F) CHO in vitro translation with increasing amounts of tRNAPro half added. (G)
Quantification of ProTiP formation of three in vitro translation reactions as a function of increasing tRNAPro 5ʹ half concentration. The horizontal lines indicate the
mean and the error bars show standard deviations. In (A), (C), (E), and (F) the coomassie stained protein bands of the lysate serve as a loading control. In (B) and (D)
significant differences were determined using the 2-tailed paired Student’s t-test (***p < 0.001, **p < 0.01, *p < 0.05).
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a control, northern blot analysis was performed on the same gel
using a probe against the 5.8S rRNA. After polyadenylation, the
5.8 S rRNA signal was quantitatively upshifted on the gel
demonstrating efficient poly(A) addition (Fig. 6B). Therefore,
the insensitivity of ProTiP to polyadenylation demonstrates that
it does not contain a free 3ʹ OH end. Electrophoretic mobility of
ProTiP within the size range of tRNAs on acidic gels and the
insensitivity to polyadenylation suggests that ProTiP could be
a tRNA with one or several amino acids attached to its 3ʹ end
thus resembling aminoacyl – or peptidyl-tRNAs, respectively.
To distinguish if ProTiP is an aminoacyl-tRNA or
a peptidyl-tRNA, copper sulphate treatment was performed.
Copper sulphate selectively deacylates aminoacyl-tRNAs with
a free N-terminus but leaves peptidyl-tRNA intact [22]. This
method is based on the ability of heavy metal ions to form
stable complexes with α-amino acid esters and to promote
hydrolysis of the ester bond, while any substituent on the α-
carbon of the amino acid ester decreases the rate of hydrolysis
[23]. Copper sulphate treatment on RNA extracted after
in vitro translation showed that ProTiP stays intact while the
methionyl-tRNAs were effectively deacylated (Fig. 6C).
Polysome profiling performed after in vitro translation reac-
tions in the absence or presence of the tRNAPro 5ʹ half showed
that addition of tRNAPro half leads to a slight but reproducible
increase of the 80S monosome peak on polysome gradients
(Fig. S9). To trace ProTiP within the density gradient, frac-
tions of the polysome gradient were subjected to RNA pre-
cipitation and the samples subsequently loaded on
a denaturing SDS gel. The autoradiogram of the dried gel
reproducibly showed the association of ProTiP with the 80S
monosome fraction (Fig. 6D). Cumulatively, the presented
evidence suggests that ProTiP is a tRNAPro 5ʹ half-
dependent translation product composed of both an RNA
and a peptidyl part and is likely a peptidyl-tRNA. To sub-
stantiate this conclusion, two control experiments were per-
formed. First, we subjected ProTiP to low concentrations of
RNase T1 or RNase I and expected the radioactive signal to
down shift in denaturing gels. Indeed, the full-length ProTiP
band diminished with the concomitant appearance of specific
shorter radioactive products as one would expect if ProTiP is
a peptidyl-tRNA (Fig. S10). Second, we designed ribosome-
binding competition experiments of 35S-ProTiP with deacy-
lated tRNAs under P-site binding conditions. Indeed, the
signal of ribosome-bound ProTiP reproducibly decreased
upon tRNA addition indicating that they share an overlapping
binding site on the 80S ribosome (Fig. 6E, F).
Figure 4. Effect of the tRNAPro half on translation in different eukaryotic systems. Autoradiograms of in vitro translation reactions performed using (A) HeLa, (B) HEK
and (C) yeast extracts in the absence or presence of the tRNAPro 5ʹ half. Cycloheximide (CHX) with an f.c. of 7.5 mg/ml was used to inhibit global translation. ProTiP is
indicated with a black arrowhead. (D) In vitro translation using CHO extracts and ProTiP formation (arrow head) was monitored in the presence of increasing amounts
of cycloheximide (CHX). (E) Formation of ProTiP in vivo. 300 pmol of synthetic tRNAPro half was transfected into HeLa cells and the cells were subsequently incubated
with S35 methionine. RNA isolated after metabolic labelling performed with (+) or without (-) transfected tRNAPro half was separated on a denaturing gel and
visualized via autoradiography. The ethidium brome (EtBr) strained gel serves as a loading control. (F) Autoradiogram of in vitro translation reactions with HeLa
ribosome-containing pellets (P100) or the corresponding ribosome-free supernatants (S100). Newly synthesized proteins, as well as ProTiP (black arrowhead), were
produced only once P100 and S100 were combined. 100 pmol of tRNAPro half was used. (G) Inhibition of global translation in CHO extracts and ProTiP formation in
the absence (-) or presence (+) of harringtonine (f.c. 2.5 mg/ml). In (A), (B), (C), (D), (F), and (G) the coomassie stained protein gels serve as loading controls.
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Discussion
In this study, we screened for tRNA halves and tRNA fragments
(tRFs) in variousmammalian cell lines and uncovered a ribosome-
associated tRNAPro 5ʹ half (Fig. 1C-E and Fig. S2). Ribosome
association was confirmed in vitro via filter binding assays and
photo-crosslinking experiments (Fig. 2). Addition of synthetic
tRNAPro 5ʹ half to in vitro translation reactions showed unique
effects on protein biosynthesis. First, the tRNAPro 5ʹ half inhibits
global translation (Fig. 3A-D). Previously, it has been described
that several stress-induced tRNA 5ʹ halves (5ʹ tiRNAs) inhibit
translation in human cells by titrating away crucial translation
initiation factors [24] and promote stress granule formation [25].
In contrast to the previously described tiRNAs, the tRNAPro 5ʹ half
identified here does not contain the 5ʹ terminal oligoguanosine
motif uncovered before on tiRNAs of being central for its inhibi-
tory function and it also does not show stress-dependent expres-
sion (Fig. 1A).Moreover, while a DNA analogue of a 5ʹ tiRNAwas
sufficient to inhibit translation [26], aDNAversion of the tRNAPro
half failed to inhibit protein biosynthesis (Fig. S5). These findings
also suggest that the interaction of the tRNA half with the rRNA
target is not entirely depending on simple base pairing. Altogether,
our data suggest that the tRNAPro 5ʹ half possesses a so far
unknown mechanism of translation inhibition in mammalian
cells. The second effect of the 5ʹ tRNAPro half on translation was
the formation of a low molecular weight product that is bound to
Figure 5. Chemical nature of ProTiP. (A) The products of in vitro translation using CHO cell lysates were incubated with proteinase K or RNase I. Protease K digests all
newly translated and cell lysate proteins, as well as ProTiP (arrowhead). Also, RNAse I digestion removes ProTiP. The coomassie or ethidium bromide-stained gels
serve as controls for efficient protein and RNA digestions, respectively. (B) Spike-in of yeast bulk tRNA (lane 3) after CHO in vitro translation in the absence (lane 1) or
presence (lane 2) of 8 µM tRNAPro 5ʹ halves shows that ProTiP (arrowhead) migrates in the size range of tRNAs in the SDS polyacrylamide gel used. The gel was
stained with coomassie (loading control) or with ethidium bromide (for visualization of the spiked-in tRNAs). (C) In vitro translation reactions (with or without tRNAPro
halves) were loaded before (-) or after (+) phenol/chloroform/isoamyl alcohol (PCI) extraction on a denaturing SDS gel. ProTiP (black arrowhead) can be extracted
into the water phase during PCI treatment. (D) Autoradiogram of an SDS polyacrylamide gel after in vitro translation in the presence of the internally 32P-labelled
tRNAPro half (open arrowhead). Migration of the labelled tRNAPro half did not change after reactions in the presence of the cell lysate and the translational mix, thus
demonstrating that ProTiP does not contain the tRNAPro 5ʹ half. Expected size of ProTiP is indicated with the black arrowhead.
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80Smonosomes (Fig. 6D) andmigrates like a ~ 17 kDa product in
SDS gels (Fig. 3A,C,E,F). The tRNAPro half–induced product
(named ProTiP) was not only observed in vitro but also after the
transfection of tRNAPro halves into HeLa cells (Fig. 4E). By per-
forming streptavidin pull-down experiments employing a 3ʹ bio-
tinylated tRNAPro half after in vitro translation (Fig. S8), or by
utilizing a 32P-labelled tRNAPro half during the translation
reaction (Fig. 5D), we could exclude the possibility that the
tRNAPro half itself is part of ProTiP. Both, translation inhibition
and ProTiP formationwere observed in several eukaryotic transla-
tion systems therefore indicating a conserved function and ribo-
some-binding site of the tRNAPro 5ʹ half (Fig. 4A-C). Cumulative
experimental evidence indicates that ProTiP is a hybrid molecule
containing both an RNA and a peptidyl part (Fig. 5A, C and Fig.
Figure 6. ProTiP is likely a peptidyl-tRNA. (A) Autoradiogram and ethidium bromide staining of an acidic gel after in vitro translation performed in the absence (-) or
presence (+) of the tRNAPro 5ʹ half. Charged tRNAiMet and tRNAMet are labelled by asterisks. ProTiP is indicated with the black arrowhead. (B) Autoradiogram of an 8%
denaturing polyacrylamide gel showing the position of ProTiP (arrowhead) before (-) and after (+) polyadenylation. Middle and left panels: Ethidium bromide staining
and northern blot against 5.8S rRNA demonstrates the efficiency of polyadenylation. (C) Copper sulphate treatment of RNA isolated after in vitro translation
performed in the presence (+) or absence (-) the tRNAPro half. The location of ProTiP, which was insensitive to copper sulphate treatment, is indicated in the
autoradiogram with the black arrowhead. The Met-tRNAMet molecules are labelled with asterisks. (D) Fractions of the polysome profile after in vitro translation in the
presence of the tRNAPro half were subjected to isopropanol precipitation. Precipitated RNA was separated on a denaturing gel and visualized via phosphorimaging.
ProTiP is indicated with the black arrowhead. (E) Binding of ProTiP to purified HeLa 80 S in vitro with and without pre-incubated bulk tRNAs. Ribosome-bound 35S-
ProTiP was determined by filter binding. (F) Quantification of three individual binding experiments. Values were normalized to the binding of ProTiP to ribosomes
without the addition of bulk tRNAs. The error bars show standard deviations (*p < 0.05).
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S10). Furthermore, ProTiP migrates in denaturing gels in the size
range of tRNAs (Figs. 5B and 6A-C), associates with 80S mono-
somes in polysome profiles (Fig. 6D) and can be chased off the
ribosome by tRNA addition (Fig. 6E,F). Taken together the
obtained data are in line with the conclusion that ProTiP is
a peptidyl-tRNA.
Previous studies have shown that under certain conditions
distinct aminoacyl-tRNAs are modified at the N-terminus result-
ing in the block of translation [27,28]. In both cases, the produced
modified aminoacyl-tRNAs were detected as a sharp clean band
migrating on polyacrylamide gels in the region of the tRNA pool,
in a similar fashion like ProTiP. However, if ProTiP was an
N-terminally modified aminoacyl-tRNA, its production would
not be translation dependent and ProTiP would migrate together
with free tRNAs on polysome profiles after in vitro translation.
The fact that after in vitro translation ProTiP stays associated with
80S monosomes, but was absent in the light density gradient
fractions containing unbound RNAs (Fig. 6D) suggests that the
accumulated product is a peptidyl-tRNA rather than N-modified
aminoacyl-tRNA. Thus, our data are compatible with the scenario
that binding of the tRNAPro 5ʹ half to ribosomes might lead to
ribosome stalling, and consequently to translation inhibition fol-
lowed by the accumulation of peptidyl-tRNA(s) (ProTiP) (Fig. 7).
Despite the fact that we were unable to unequivocally identify the
molecular nature of ProTiP by a variety of complementary meth-
ods, several conclusions can be drawn based on our findings.
Since ProTiP always migrates as a sharp band on denaturing
gels suggests that it contains one specific tRNA body but could
still be heterogeneous in the length and composition of the pepti-
dyl part. As ProTiP is produced in different translation systems on
different mRNAs, it is likely that the formed peptidyl-tRNAs have
heterogeneous amino acid sequences with a varying number of
residues. Variation in the amino acid sequence and slight differ-
ences of the peptidyl length would not dramatically change the
bulk charge of the peptidyl-tRNA, and consequently its migration
on denaturing polyacrylamide gels. Therefore, it is reasonable to
assume that ProTiP represents a group of peptidyl-tRNAs with
one particular tRNA body and different short peptidyl chains. The
ability to extract ProTiP during a phenol/chloroform treatment
into the water phase indicates that the peptidyl part is probably
shorter than 80 amino acids [29]. Since cycloheximide allows only
one round of elongation after ribosome binding [30], the produc-
tion of ProTiP in the presence of cycloheximide pre-incubated
with ribosomes (see Material and Methods) suggests that the
peptidyl part contains only a few amino acids.
Some of the previously identified tdRs, including short tRFs as
well as tRNA half molecules, have been appreciated in the recent
past of possessing biological roles in various model organisms and
are therefore more than degradation intermediates of tRNA
homoeostasis. Accumulating evidence suggests that tdRs are
a functionally very heterogonous class of ribo-regulators
[2,6,31]. A subclass of these tRNA fragments effectively associates
with the ribosome and are therefore included into the growing
class of ribosome-associated ncRNAs (rancRNAs) [9]. However,
even those tdRs that target the ribosome turned out to influence
protein production in a markedly different manner. While some
affect translation globally in an inhibitory [12,24] or stimulatory
[15] manner, the tRNAPro 5ʹ half reported here, reveals yet
another aspect of tdR biology. While it is functionally analogous
to previously identified tRNA 5ʹ halves [24] in the sense that it
globally down regulates protein production, it is unique in trigger-
ing the formation of ProTiP, a small molecular weight product.
Our attempts to characterize the molecular nature of ProTiP
suggest that it is peptidyl-tRNA likely produced as a consequence
of tRNAPro half-mediated ribosome stalling. Future work will
have to reveal whether ProTiP is a mere byproduct of the ribo-
some arrest or if it possesses a physiological role by itself. While
previously reported tRNA halves capable of inhibiting translation
were generated by angiogenin specifically during certain stress
conditions, called tiRNAs [24], the tRNAPro 5ʹ half reporter herein
is produced in a stress-independent manner. Therefore, it is safe
to suspect that the tRNAPro 5ʹ half is generated via a different
biogenesis pathway and it might fulfil a cellular role distinct from
tiRNAs in mammalian cells.
Materials and methods
Cell cultivation and stress application
CHO-K1 cells were cultivated in CD CHO medium (Gibco)
supplemented with 8 mM glutamine (Gibco), 1x PenStrep
(Gibco), and 2 ml/l anticlumping agent (Gibco) at 37ºC, 5%
Figure 7. Model of the effect of the tRNAPro 5ʹ half on translation. The tRNAPro is processed into the tRNAPro 5ʹ half through cleavage at the anticodon region. The
tRNAPro 5ʹ half binds to the ribosome and likely causes ribosome stalling. Consequently, translation is inhibited globally resulting in the accumulation of the peptidyl-
tRNA inside the stalled ribosomes that we identified as ProTiP.
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CO2. CHO cells were harvested during exponential growth at
approximately 48 h after seeding with a cell density of 0.2 × 106
cells/ml. HEK cells were cultivated in DMEM medium (Gibco)
supplemented with 10% FCS (Thermo Scientific), 4 mM
Glutamine (Gibco), and 1 x PenStrep (Gibco). For HeLa cells
RPMI (Gibco) medium supplemented with 10% FCS, 4 mM glu-
tamine (Gibco) and 1 x PenStrep (Gibco) was used. For northern
blot analysis, the following stress conditions were applied: (I)
stationary growth phase: for CHO-K1 cells 7 days after seeding
with a cell density of 0.2 × 106 cells/ml, for HeLa and HEK cells
growth to the overconfluent stage, (II) heat shock treatment: 42°C
for 30 min, (III) oxidative stress: incubation with 2 mMH2O2 for
2 h, (IV) recovery from oxidative stress: 2 mM H2O2 for 2 h
followed by 2 h recovery in fresh media, (V) nutritional depriva-
tion by incubation the cells in PBS for 2 h.
Northern blot analysis
For northern blotting, 10–30 μg of RNA was separated by dena-
turating polyacrylamide gels (7 M urea) and subsequently electro-
blotted onto nylon membranes (Amersham Hybond N+, GE
Healthcare) as described [13]. All membranes were hybridized
to a 32P-5′-end-labelled DNA probe complementary to the 5ʹ part
of tRNAPro AATCATACCCCTAGACCAACGAGCC.
Bulk ribosome pelleting
To generate crude ribosomal pellets, cell lysates were loaded on
0.5 ml 1.1 M sucrose cushion in 30 mMHepes pH 7.6, 150 mM
KOAc, 3.9 mM Mg(OAc)2, 4 mM DTT, 1 mM PMSF and
centrifuged for 2.5 h at 200,000 xg in a Sorval M120+ miniul-
tracentrifuge equipped with an S140AT rotor (Thermo
Scientific). Obtained ribosomal pellets were resuspended in 1
x resuspension buffer (30 mM HEPES-KOH, pH 7.6; 150 mM
KOAc, 3.9 mM Mg(OAc)2; 4 mM DTT; 1 x Tm complete
(Roche); RNase inhibitor (Thermo Fisher or Promega). To pre-
pare the more concentrated S100 extracts used in HeLa in vitro
translation experiments, the cell lysate was directly ultracentri-
fuged without a sucrose cushion.
Polysome profiling
For polysome profiling, exponentially growing cells were treated
with freshly prepared cycloheximide to an f. c. of 100 µg/ml for
10 min. Cells were washed with PBS containing 100 µg/ml
cycloheximide and opened in 1 x resuspension buffer contain-
ing 100 µg/ml cycloheximide by passing through a 25 G needle
30 times. Cell lysates were layered onto a 10–50% (w/v) linear
sucrose gradient prepared in 30 mM HEPES-KOH, pH 7.6;
150 mM KOAc; 5 mM Mg(OAc)2, 4 mM DTT; 1 mM PMSF;
100 µg/ml cycloheximide. Samples were centrifuged at 39 krpm
for 2 h 45 min at 4°C using an SW-41 swing-out rotor
(Beckman). The gradient was pumped out from the top to the
bottom using a Density Gradient Fractionation System
(Brandel). Polysome profiles were generated by continuous
measurement of the absorbance at 254 nm.
Ribosome filter binding
In order to investigate the binding of the tRNAPro 5ʹ half to
ribosomes and ribosomal subunits, the tRNAPro half was radio-
actively labelled at the 5ʹend with P32 – ATP or at the 3ʹ end with
P32–pCp. For the binding reaction, 5 pmol of 80S/60S/40S was
incubated with P32 tRNAPro half in 1 x binding buffer (30 mM
HEPES-KOH, pH 7.6, 150 mM KOAc, 3.9 mM Mg(OAc)2) for
30 min at 35°C for CHO ribosomes and at 30°C for yeast ribo-
somes/ribosomal subunits. The reaction was diluted by the addi-
tion of 175 μl 1 x binding buffer. Then, samples were filtrated as
described before [12]. As negative binding control an archaeal
ncRNA was used (5ʹ-CAGAGUAACCCCUCGGACGCAUCC
ACAUGACCGAACUCAUCCCCCCUUCCCCCCUUCCCCA-
UUAGGUUCGGUCACCCCUUUA-3) (ref. 20).
In order to characterize the binding site of ProTiP on HeLa
ribosomes by binding competition experiments with deacylated
tRNA, ProTiP was first produced in in vitro translation reaction
in the presence of the tRNAPro half in 20 replicates (see details
below). To deplete endogenous tRNAs from the ribosome pool
and to remove unincorporated S35methionine, all reactions were
pooled and subjected to ultracentrifugation for 1 h at 200,000 xg
in a Sorval M120+ mini-ultracentrifuge equipped with an
S140AT rotor (Thermo Scientific). To deacylate tRNAMet, the
obtained pellet was resuspended in 2 x Laemmli buffer and
boiled for 5 min at 95°C. Then, RNA was extracted using
phenol/chloroform and the RNA pellet was resuspended in
70 μl water. For the binding competition reaction, 5 pmol of
sucrose gradient – purified HeLa 80 S ribosomes in 1 x resuspen-
sion buffer in a volume of 18 μl was pre-incubated with 1 μl
water or 1 μl of 40 μM yeast bulk tRNAs for 10 min at 35°C and
450 rpm. After pre-incubation, 5 μl of ProTiP-containing RNA
was added to each sample and the reactions were incubated for
another 10min at 35°C and 450 rpm. Subsequently, the reactions
were diluted by the addition of 175 μl 1 x binding buffer. Finally,
the samples were filtered as described before [12].
Crosslinking of 4–Thio-U-tRNAPro half to HeLa ribosomes
For the crosslinking experiments, 5–10 pmol of 5ʹ P32 labelled
synthetic tRNAPro half carrying three photo-reactive 4-thiouridine
residues at positions 4, 13, and 27 was incubated with 10 pmol of
HeLa ribosomal pellet in 1 x resuspension buffer in a final volume
of 20 μl for 15 min at 35°C and 450 rpm. Crosslinking was
performed on ice at 366 nm for 10 min as described before [12].
After crosslinking, samples were subjected first to protease
K treatment (f.c. 0.5 mg/ml of protease K, incubation for 30 min
at 37°C), and then to phenol/chloroform extraction RNA extrac-
tion. Obtained RNA was resuspended in 20 μl of water. To test if
the 32P-labled tRNAPro half was crosslinked to the rRNAs, 3 μl of
RNA was separated on 1% agarose gel. After staining with ethi-
dium bromide, the agarose gel was vacuum-dried at 70°C for 2 h
and exposed to a phosphor imaging screen overnight. To narrow
down the crosslinking site(s) of tRNAPro half on the 18 S rRNA,
RNase H cleavage experiments were performed with DNA oligos
annealing to different regions of 18S rRNA (18 S_563-582:
AAAGGATTTAAAGTGGACTC, 18S_653-672: TTTTTAACTG
CAGCAACTTT, 18 S_1247-1266: GTGAGGTTTCCCGTGTTG
AG, 18S_1375-1394: CCAGAGTCTCGTTCGTTATC, 18S_154
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4-1563: CGTAGGGTAGGCACACGCTG). Prior to RNase
H treatment, the extracted crosslinked RNAs were denatured at
70°C for 2min. Each reaction contained 3 μl of denaturedRNA, 10
pmol DNA oligo, 1x RNase H buffer (New England Biolabs),
RNase inhibitor RNasine (Promega), and 3 U of RNase
H. Cleavage was performed at 37°C for 1 hour. Cleavage products
were analysed on 4% polyacrylamide gels containing 7 M urea.
After staining with ethidium bromide, gels were vacuum-dried at
70°C for 2 h and exposed to phosphorimager screens.
In vitro translation
Harvested cells were resuspended in equal volume of 1
x resuspension buffer. Cells were opened by passing through
a 25 G needle 30 times. Cell debris was removed by centrifugation
at 20,000 xg for 15 min at 4°C. To deplete endogenous methio-
nine, the cell lysate was passed through a G25 sephadex spin
column prepared in 30 mM HEPES pH 7.6, 150 mM KOAc,
3.9 mMMg(OAc)2. Every in vitro translation reaction at the pre-
incubation step had a total volume of 9.9 μl and contained 6–7 μl
of cell lysate and 2.9–3.9 μl of water. For translation inhibition by
antibiotics, cycloheximide, or harringtonine was dissolved in abs.
ethanol and added first to the tubes and the solvent was evapo-
rated. To test the effect of tRNA 5ʹ halves on translation 100–200
pmol of synthetic RNAs were added to the reactions (tRNAPro 5ʹ
half GGCUCGUUGGUCUAGGGGUAUGAUUCUCGCUUA
GG, tRNAAsp 5ʹ half UCCUCGUUAGUAUAGUGGUGAGU
AUCCCCGCCUG, tRNAHis 5ʹ half GCCGUGAUCGUAUAG
UGGUUAGUACUCUGCGUUG, tRNAAsn 5ʹ half GUCUCU
GUGGCGCAAUCGGUUAGCGCGUUCGGCUG). Reactions
were pre-incubated at 35°C at 450 rpm for 10 min. After pre-
incubation, 2.1 μl of freshly prepared translational mix consisting
of 1.2 µl 10 x translation cocktail (150 mMHEPES-KOH, pH 7.6,
750 mM KOAc, 19.5 mMMg(OAc)2, 4 mM GTP, 17.5 mM ATP
and 500 µM each of all 19 amino acids except methionine), 0.17 µl
water, 0.08 µl 3 M creatine phosphate, 0.06 µl 20 mg/ml creatine
phosphokinase and 0.625 µl S35-Methionine was added to every
pre-incubated mixture increasing a total volume of reaction to
12 μl. In vitro translation was performed at 35°C at 450 rpm for
30 min. Reactions were stopped by the addition of 4 µl of 4
x Laemmli buffer and boiling at 95°C for 5 min.
For the translation of one reporter mRNA, Xef1 mRNA
(Thermo Scientific) and rabbit reticulocyte cell lysate (Thermo
Scientific or Promega) were used according to the manufac-
tory’s protocol. To test the effect of tRNA halves on transla-
tion 50–150 pmol of synthetic RNAs were used. In vitro
translation was stopped by the addition of Laemmli buffer
and heating at 95°C for 5 min.
Samples were separated on 10-14% SDS-PAGE, stained with
Coomassie Brilliant Blue and destained (several hours to over-
night). For RNA visualization, gels were stained by soaking in a 1
x TBE solution containing 0.5 µg/ml ethidium bromide for
5–10 min. Afterwards, the gel was vacuum-dried at 70°C for 1 h
and exposed to phosphor imaging screen overnight.
Metabolic labelling
For metabolic labelling experiments, Hela cells were grown in
48-well plates to around 90% confluence. To transfect RNA
into HeLa cells, 100 µl of FBS free Opti-MEM medium
(Gibco) were combined with 300 pmol of the tRNAPro half,
10 µl or 50 µl of Lipofectamine RNAi MAX (Invitrogen) and
incubated for 5 min at room temperature. Then, the mixture
was added to one well and the cells were kept at 37°C and 5%
CO2 for 5 min. To start the metabolic labelling 1 µl of S
35
methionine (10 μCi/μl, Hartmann Analytic) was added to
each well and the cells were incubated for another 30 min.
Afterwards, the RNA was isolated with TRI reagent and
separated on 12% SDS PAGE. To check the efficiency of
RNA isolation and equal loading, the gel was stained with 1
x TBE containing 0.5 µg/ml ethidium bromide for 5–10 min.
The gel was vacuum-dried at 70°C and exposed for 1 week to
a phosphor imager screen to visualize ProTiP.
Acidic gel electrophoresis
To separate charged tRNAs, RNA were separated on freshly
prepared 15% denaturing urea acidic polyacrylamide gels (8 M
Urea, 50 mMCH3 COONa pH 5.5). For the loading one volume
of the RNA sample was combined with one volume of loading
dye (93% v/v formamide, 150 mM NaOAc, pH 5.5; 10 mM
EDTA, bromphenol blue, xylene cyanol). Subsequently, the gel
was stained with 1 x TBE containing 0.5 µg/ml ethidium bro-
mide for 10–15 min. The gel was vacuum-dried at 70°C and
exposed overnight to a phosphorimaging screen.
Polyadenylation
To characterize the 3ʹ end of ProTiP, total RNA was extracted
from in vitro translation reactions performed in the presence of
tRNAPro 5ʹ half and subjected to polyadenylation. Each reaction
(total volume of 20 µl) contained 2 µl of 10 x Poly(A)Pol buffer
(New England Biolabs), 1 µl RNA template (corresponding to 0.2
x of one in vitro translation reaction), 4 µl of 10 mM ATP, 1 µl
RNasine (Promega), and 2 µl of Poly(A) Polymerase (New
England Biolabs). Polyadenylation was carried out for 30 min at
37⁰C in a water bath. The reaction was stopped by addition of
22 µl of 2 x RNA loading dye. Afterwards, samples were separated
on denaturing 8% polyacrylamide 7 M Urea 1 x TBE gel. After
RNA separation, the gel was stained with 1 x TBE containing
0.5 µg/ml ethidium bromide for 10–15 min and then dried for 3 h
at 70 ⁰C under vacuum. To detect the S35 signal of ProTiP, the
dried gel was exposed to a phosphor imaging screen overnight.
After the screen was scanned, the dried gel was rehydrated by
incubation in 1 x TBE containing 0.5 µg/ml ethidium bromide.
Once the gel was rehydrated, the quality of the RNA in the gel was
checked under the UV light. To control for correct polyadenyla-
tion, the gel was blotted onto a nylonmembrane and subsequently
probed against 5.8S rRNA TCCTGCAATTCACATTAAT
TCTCGAGCTAGC by northern blot analysis.
Copper sulphate treatment
Copper sulphate treatment was performed using a protocol
developed previously [22] on RNA isolated after in vitro trans-
lation with CHO cell lysate. Each reaction in a total volume of
30 µl contained 40 mM CuSO4 x 5 H2O, 40 mM Tris, pH 7.5, or
pH 8.9 and RNA isolated from 3 in vitro translation reactions.
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Reactions were incubated at 37°C for 1 h and afterwards sub-
jected to RNA extraction. After PCI extraction, 1/10 of the
obtained RNA was loaded on a 15% acidic gel.
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